199 related articles for article (PubMed ID: 28590601)
1. Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States.
Tohen M; Ng-Mak D; Rajagopalan K; Halpern R; Chuang CC; Loebel A
Prim Care Companion CNS Disord; 2017 Jun; 19(3):. PubMed ID: 28590601
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics.
Ng-Mak D; Halpern R; Rajagopalan K; Loebel A
Curr Med Res Opin; 2019 Feb; 35(2):211-219. PubMed ID: 29625538
[TBL] [Abstract][Full Text] [Related]
3. Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study.
Kadakia A; Dembek C; Liu Y; Dieyi C; Williams GR
J Med Econ; 2021; 24(1):1212-1220. PubMed ID: 34647502
[TBL] [Abstract][Full Text] [Related]
4. Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
Rajagopalan K; Wade S; Meyer N; Loebel A
Curr Med Res Opin; 2017 May; 33(5):813-820. PubMed ID: 28098496
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data.
Niu X; Veeranki P; Dennen S; Dembek C; Laubmeier K; Liu Y; Williams GR; Loebel A
Curr Med Res Opin; 2021 May; 37(5):839-846. PubMed ID: 33682547
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression.
Rajagopalan K; Meyer K; O'Day K; Denno M; Loebel A
J Med Econ; 2015; 18(10):821-7. PubMed ID: 25985265
[TBL] [Abstract][Full Text] [Related]
7. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
Kim E; You M; Pikalov A; Van-Tran Q; Jing Y
BMC Psychiatry; 2011 Jan; 11():6. PubMed ID: 21214937
[TBL] [Abstract][Full Text] [Related]
8. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
9. Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment.
Broder MS; Greene M; Yan T; Chang E; Hartry A; Yermilov I
Clin Ther; 2019 Feb; 41(2):221-232. PubMed ID: 30616973
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.
Jiang Y; Ni W
Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
Gianfrancesco F; Pesa J; Wang RH
J Manag Care Pharm; 2005 Apr; 11(3):220-30. PubMed ID: 15804206
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
13. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
[TBL] [Abstract][Full Text] [Related]
14. Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
Yan T; Greene M; Chang E; Houle CR; Waters HC; Tarbox MH; Broder MS
Clin Ther; 2020 Jan; 42(1):77-93. PubMed ID: 31928831
[TBL] [Abstract][Full Text] [Related]
15. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H
Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804
[TBL] [Abstract][Full Text] [Related]
16. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
[TBL] [Abstract][Full Text] [Related]
17. Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
Niu X; Dennen S; Dembek C; Laubmeier K; Liu Y; Veeranki P; Tocco M; Williams GR
Curr Ther Res Clin Exp; 2021; 94():100629. PubMed ID: 34306269
[No Abstract] [Full Text] [Related]
18. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
[TBL] [Abstract][Full Text] [Related]
19. Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazine.
Huang H; Schmerold L; Dembek C; Fan Q; Dieyi C; Williams GR; Loebel A
J Med Econ; 2021; 24(1):352-362. PubMed ID: 33588674
[TBL] [Abstract][Full Text] [Related]
20. Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis.
Newcomer JW; Ng-Mak D; Rajagopalan K; Loebel A
BMC Health Serv Res; 2018 Apr; 18(1):243. PubMed ID: 29618351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
